Bystander LECT2 amyloidosis in tumor nephrectomy.

CEN Case Rep

Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.

Published: February 2023

Pathologic evaluation of the non-neoplastic renal parenchyma in tumor nephrectomy specimens is critical and can detect both renal-limited and systemic pathologies. We report the case of a 69-year-old Punjabi male who underwent cytoreductive nephrectomy for advanced renal cell carcinoma after immunotherapy. We detected clinically unexpected leukocyte chemotactic factor 2 (LECT2) amyloidosis during pathologic analysis of the surrounding non-neoplastic renal parenchyma, which was confirmed by mass spectrometry. LECT2 amyloidosis occurs predominantly in Hispanic patients and has only rarely been described in Punjabi patients. This case highlights the importance of careful pathologic evaluation of the non-neoplastic renal parenchyma of nephrectomy specimens and raises awareness that LECT2 amyloidosis can occur outside of the typical demographic of Hispanic patients.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892383PMC
http://dx.doi.org/10.1007/s13730-022-00728-9DOI Listing

Publication Analysis

Top Keywords

lect2 amyloidosis
16
non-neoplastic renal
12
renal parenchyma
12
tumor nephrectomy
8
pathologic evaluation
8
evaluation non-neoplastic
8
nephrectomy specimens
8
hispanic patients
8
bystander lect2
4
amyloidosis
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!